Dan Brennan
Stock Analyst at TD Securities
(3.66)
# 698
Out of 4,829 analysts
107
Total ratings
45.88%
Success rate
7.27%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $56 → $60 | $41.72 | +43.82% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $59.14 | +86.00% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $1.99 | +25.94% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $61.37 | +20.58% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $51.63 | +66.57% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $151.95 | +15.17% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $138.79 | +80.13% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $37.52 | +86.57% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $75.76 | +133.63% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $91.25 | +57.81% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $344.06 | +19.17% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $189.73 | +66.03% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $106.93 | +49.63% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $3.89 | +671.21% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $12.02 | +157.90% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $403.13 | +63.22% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $43.61 | +16.95% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.37 | +653.50% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $8.05 | +148.45% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $8.77 | +264.88% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $279.77 | +95.16% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.87 | +274.33% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.12 | +1,239.29% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $133.96 | +73.19% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,080.98 | -18.59% | 3 | Oct 7, 2020 |
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $41.72
Upside: +43.82%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $59.14
Upside: +86.00%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $1.99
Upside: +25.94%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $61.37
Upside: +20.58%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $51.63
Upside: +66.57%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $151.95
Upside: +15.17%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $138.79
Upside: +80.13%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $37.52
Upside: +86.57%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $75.76
Upside: +133.63%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $91.25
Upside: +57.81%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $344.06
Upside: +19.17%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $189.73
Upside: +66.03%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $106.93
Upside: +49.63%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $3.89
Upside: +671.21%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $12.02
Upside: +157.90%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $403.13
Upside: +63.22%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $43.61
Upside: +16.95%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.37
Upside: +653.50%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $8.05
Upside: +148.45%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $8.77
Upside: +264.88%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $279.77
Upside: +95.16%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.87
Upside: +274.33%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.12
Upside: +1,239.29%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $133.96
Upside: +73.19%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,080.98
Upside: -18.59%